Detalhe da pesquisa
1.
Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy.
Angiogenesis
; 26(2): 279-293, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459240
2.
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
Eur J Nucl Med Mol Imaging
; 50(7): 2068-2080, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36859619
3.
Tissue Resistance Decrease during Irreversible Electroporation of Pancreatic Cancer as a Biomarker for the Adaptive Immune Response and Survival.
J Vasc Interv Radiol
; 34(10): 1777-1784.e4, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391072
4.
Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes.
Proc Natl Acad Sci U S A
; 117(44): 27528-27539, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33067394
5.
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes.
Haematologica
; 107(3): 655-667, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567812
6.
From simplicity to complexity in current melanoma models.
Exp Dermatol
; 31(12): 1818-1836, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103206
7.
A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid Malignancies.
Oncologist
; 26(2): e218-e229, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33105058
8.
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy.
Curr Oncol Rep
; 23(6): 68, 2021 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864144
9.
Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.
Int J Mol Sci
; 22(3)2021 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33499253
10.
Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10.
Cancer Immunol Immunother
; 69(11): 2319-2331, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507967
11.
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy.
Radiology
; 295(2): 254-272, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208094
12.
Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Radiology
; 294(1): 212-220, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31687922
13.
Improving CLL Vγ9Vδ2-T-cell fitness for cellular therapy by ex vivo activation and ibrutinib.
Blood
; 132(21): 2260-2272, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213872
14.
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation.
Haematologica
; 105(4): 961-971, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273091
15.
Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial.
BMC Cancer
; 20(1): 764, 2020 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32795284
16.
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
BMC Cancer
; 20(1): 380, 2020 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32370765
17.
Unlocking the therapeutic potential of primary tumor-draining lymph nodes.
Cancer Immunol Immunother
; 68(10): 1681-1688, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944963
18.
Correction to: Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.
Cancer Immunol Immunother
; 68(6): 1037, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919028
19.
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.
Cancer Immunol Immunother
; 68(2): 319-329, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30413837
20.
Metronomic cyclophosphamide attenuates mTOR-mediated expansion of regulatory T cells, but does not impact clinical outcome in patients with metastatic renal cell cancer treated with everolimus.
Cancer Immunol Immunother
; 68(5): 787-798, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756132